Clinical consequences of polypharmacy in elderly

Author： Maher Robert L   Hanlon Joseph   Hajjar Emily R  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.1, 2014-01, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polypharmacy, the Elderly, and Deprescribing

By JethaShirinContinuing Competency Department   Ontario College of Pharmacists   Toronto   Ontario   Canada  

The Consultant Pharmacist, Vol. 30, Iss. 9, 2015-09 ,pp. : 527-532

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Psychiatric Polypharmacy, Etiology and Potential Consequences

By  

Current Psychopharmacology, Vol. 6, Iss. 1, 2017-04 ,pp. : 12-26

Bentham Science Publishers

Access to resources Recommend Favorite

Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist

By Rollason V.   Vogt N.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 817-832

Adis International

Access to resources Recommend Favorite

Polypharmacy Status as an Indicator of Mortality in an Elderly Population

By Jyrkkä Johanna   Enlund Hannes  

Drugs & Aging, Vol. 26, Iss. 12, 2009-12 ,pp. : 1039-1048

Adis International

Access to resources Recommend Favorite

Is It Possible to Reduce Polypharmacy in the Elderly?: A Randomised, Controlled Trial

By Pitkala K.H.   Strandberg T.E.   Tilvis R.S.  

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 143-149

Adis International

Access to resources Recommend Favorite